Create an Account

Already have account?

Forgot Your Password ?

Home / Questions / Neopure Corporation has developed an artificial haemoglobin that can be used in place of b

Neopure Corporation has developed an artificial haemoglobin that can be used in place of b

Neopure Corporation has developed an artificial haemoglobin that can be used in place of blood transfusions and holds the patent on this product. Therefore, Neopure has


[A]Potential external opportunities
[B]Core competencies
[C]Synergistic edge
[D]Competitive advantage

Dec 18 2017 View more View Less

Answer (Solved)

question Subscribe To Get Solution

Related Questions